Topic: neuroscience research
The spending plan will amount to an extra £83 million ($107 million) a year.
The notice comes weeks after Amgen revealed it was retreating from its East Coast neuroscience operations.
Charles River signed on to an Alzheimer's UK research consortium.
With a new, privately funded research center, Johns Hopkins is trying to jump-start psychedelic research that has been stymied since the 1970s.
Axovant is continuing its change-up with a new focus and a new exec.